ConductScience.org, home

Paper · 1104746

Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.

Debré P and 2 others. J Exp Med, 1975. Cited by 91 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. Papers, record 1104746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1104746

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.
PubMed
Journal
J Exp Med
PubMed
Year
1975
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2019-05-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Debré PP
2Kapp JAJ A
3Benacerraf BB

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
AntigensMajor topic
Immune ToleranceMajor topic
Mice, Inbred BALB CMajor topic
Animals
Glutamates
Hemolytic Plaque Technique
Immunization
Immunoglobulin G
Immunosuppressive Agents
Kinetics
Mice
Polymers
Serum Albumin, Bovine
Species Specificity
Spleen
Tyrosine

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,918,158Fractionation of nucleic acids with the methylated albumin column.J Mol Biol1962https://conductscience.org/library/papers/13918158PubMed
24,126,766
Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
J Exp Med1973https://conductscience.org/library/papers/4126766PubMed
34,137,682Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT).J Exp Med1974https://conductscience.org/library/papers/4137682PubMed
44,109,878Histocompatibility-linked immune response genes.Science1972https://conductscience.org/library/papers/4109878PubMed
54,539,650A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4539650PubMed
64,857,865Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice.J Exp Med1974https://conductscience.org/library/papers/4857865PubMed
74,750,862Mapping the H-2-linked genes governing, respectively, the immune responses to a glutamic acid-alanine-tyrosine copolymer and to limiting doses of ovalbumin.J Immunol1973https://conductscience.org/library/papers/4750862PubMed
84,908,392Genetic control of specific immune responses.Adv Immunol1969https://conductscience.org/library/papers/4908392PubMed
94,934,502Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.J Exp Med1971https://conductscience.org/library/papers/4934502PubMed
105,559,610Specific immune response genes of the guinea pig. I. Dominant genetic control of immune responsiveness to copolymers of L-glutamic acid and L-alanine and L-glutamic acid and L-tyrosine.J Exp Med1971https://conductscience.org/library/papers/5559610PubMed

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
18,154,615Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm.Immunology2008https://conductscience.org/library/papers/18154615PubMed
9,730,897Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b).J Exp Med1998https://conductscience.org/library/papers/9730897PubMed
8,747,923The SMXA: a new set of recombinant inbred strain of mice consisting of 26 substrains and their genetic profile.Mamm Genome1995https://conductscience.org/library/papers/8747923PubMed
7,106,845Differential sensitivity of lymphocyte subsets to corticosteroid treatment.Immunology1982https://conductscience.org/library/papers/7106845PubMed
7,047,670Gain/loss of poly(Glu50Tyr50)/poly(Glu60Ala30Tyr10) responsiveness in the bm12 mutant strain.J Exp Med1982https://conductscience.org/library/papers/7047670PubMed
7,011,980Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.Infect Immun1980https://conductscience.org/library/papers/7011980PubMed
6,801,188Regulation of immune responses by I-J gene products. II. Presence of Both I-Jb and I-Jk suppressor factors in (nonsuppressor x nonsuppressor) F1 mice.J Exp Med1982https://conductscience.org/library/papers/6801188PubMed
6,800,943Genetic analysis of immune suppression. I. Gene complementation is required for suppression of antigen-specific proliferative responses by T-cell derived factors.Immunogenetics1981https://conductscience.org/library/papers/6800943PubMed
6,792,727Helper and suppressor T cell factors.Springer Semin Immunopathol1980https://conductscience.org/library/papers/6792727PubMed
6,602,202Hapten-reactive inducer T cells. I. Definition of two classes of hapten-specific inducer cells.J Exp Med1983https://conductscience.org/library/papers/6602202PubMed

1 to 10 of 33

See all 33 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1104746

GET https://conductscience.org/api/papers/v1/1104746/cited_by?page=2